Inhibition of HIFAL can weaken tumor glycolysis and reduce the tumor energy supply and glycolytic products, weakening the inhibitory effect of tumor metabolic reprogramming on immune cells (122). The gene discussed is ENSG00000258667; the disease is neoplasm.